Granules India gets USFDA nod for muscle pain tablets
Granules India has received approval from the US health regulator for generic Methocarbamol tablets in two strengths used for the treatment of muscl08-05-2018
08-05-2018
Received Approval For ANDA Filed By Granules India Limited
Received approval for ANDA filed by Granules India Limited08-05-2018
Submission Of Certificate Under Regulation 40(9) Of SEBI (LODR) Of Regulations, 2015.
Certificate under regulation 40(9) of SEBI (LODR) of Regulations, 2015 certified by Saurabh Poddar & Associates, Company Secretaries for the half year ended March 31, 2018.17-04-2018
Submission Of Certificate Under Regulation 40(9) Of SEBI (LODR) Of Regulations, 2015.
Regulation 40(10) of SEBI (LODR) of Regulations, 2015.17-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 013130 Name of the Signatory :- CHAITANYA TUMMALADesignation :- Company Secretary and Compliance Officer05-04-2018
Shareholding for the Period Ended March 31, 2018
Granules India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here04-04-2018
Compliance Certificate For The Quarter Ended 31St March 2018
Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and disclosure requirements) Regulations, 2015.04-04-2018
Granules India'S Gagillapur And Jeedimetla Facilities Completed US FDA Inspection.
Granules India's Gagillapur and Jeedimetla facilities completed US FDA inspection.26-03-2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tyche Investments Pvt Ltd23-03-2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krishna Prasad Chigurupati23-03-2018